Segmentation by type differentiates plasmid products according to molecular conformation and purification tier. The primary categories are supercoiled plasmid, linearized plasmid, minicircle DNA, and circular non‑supercoiled plasmid. Within each, sub‑types such as high‑purity GMP‑grade, research‑grade, and custom‑vector are distinguished by endotoxin limits, scale of production, and sequence‑specific modifications. Supercoiled plasmid, representing the most biologically active form, commands the largest share of the market due to its prevalence in gene‑editing and therapeutic applications. Linearized and minicircle variants, while niche, are expanding in synthetic biology and vaccine sectors where reduced bacterial backbone improves expression efficiency. Circular non‑supercoiled plasmid occupies a modest portion, primarily serving cost‑sensitive academic projects. The distribution of these types directly impacts manufacturing capacity, pricing structures, and ultimately the total market valuation.